Stock Price Quote

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE78.36-4.12 (-5 %)
PREV CLOSE ( ) 82.48
OPEN PRICE ( ) 79.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3922
TODAY'S LOW / HIGH ( )78.36 82.16
52 WK LOW / HIGH ( )44.49 104.8
NSE77.48-4.07 (-4.99 %)
PREV CLOSE( ) 81.55
OPEN PRICE ( ) 81.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36896
TODAY'S LOW / HIGH( ) 77.48 82.98
52 WK LOW / HIGH ( )44.1 100.94
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-12 1976
Management Info
Babulal Jain - Chairman Kunal Gandhi - Managing Director
Registered Office

Address 4801/B & 4802/A,G I D C Industrial Estate, ,
Ankleshwar,
Gujarat-393002

Phone 02646-221422 /220549

Email companysecretary@lykalabs.com

Website www.lykalabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

17Jul Lyka Labs informs about AGM and annual
Pursuant to Regulation 34(1) of the SEBI Listing Regulations, Lyka Labs..
27May Lyka Labs informs about newspaper publ
Lyka Labs has informed that as per regulation 47 of the SEBI (LODR) Regu..
23Mar Lyka Labs informs about board meeting
Lyka Labs has informed that a meeting of the Board of Directors of the C..
23Oct Lyka Labs submits board meeting intima
Lyka Labs has informed that a meeting of the Board of Directors of the C..
11Oct Lyka Labs informs about compliance cer
In compliance with Regulation 74 (5) of the SEBI (Depositories and Parti..

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit21-322.88
Gross Profit 19.93 -332.35
Operating Profit 50.1115.6600000000001
Net Sales 423.091209.05

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  21857.25 (1.68%)
M.Cap ( in Cr)28042.61
Haleos Labs (BSE)
peergroup  1549.00 (5.87%)
M.Cap ( in Cr)468.31
NGL Fine-Chem (BSE)
peergroup  3009.65 (2.88%)
M.Cap ( in Cr)1859.37
Kwality Pharma (BSE)
peergroup  3641.50 (1.94%)
M.Cap ( in Cr)3778.49
Gland Pharma (BSE)
peergroup  2913.00 (1.37%)
M.Cap ( in Cr)48067.66

Shareholding Pattern

PROMOTERS 58.45%
NON-INSTITUTION 40.72%
FI/BANKS/INSURANCE 0.28%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Lyka Labs Ltd.

Lyka Labs Ltd. was incorporated in the year 1976. Its today's share price is 78.36. Its current market capitalisation stands at Rs 283.29 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1209.05 Cr and Total Income of Rs.1248.8 Cr. The company's management includes Shashil Mendonsa, Kunal Gandhi, Shailendra Kumar Agrawal, Archana Yadav, Neeraj Golas, Prashant Godha, Yogesh Shah, Babulal Jain.

It is listed on the BSE with a BSE Code of 500259 , NSE with an NSE Symbol of LYKALABS and ISIN of INE933A01014. It's Registered office is at 4801/B & 4802/A,G I D C Industrial Estate, Ankleshwar-393002, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are D Kothary & Co, MA Parikh & Co, Mehta Chokshi & Shah

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)